← Leaderboards
Deborah L. Fuller
Powderject Vaccines, Inc.
$17,072,697
Attributed
$24,208,536
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,331,510 · 21
By mechanism
R01$7,848,126 · 3
U01$5,771,762 · 1
R44$3,264,030 · 2
U42$2,122,974 · 1
R56$1,652,875 · 2
U19$1,628,297 · 2
Top collaborators
- David Baker5 shared
- David Veesler5 shared
- James Ivan Mullins4 shared
- Kenneth C Bagley3 shared
- Hannah Frizzell2 shared
- Kristyn Rene Aalto1 shared
- Edward A Clark1 shared
- Charlotte Hotchkiss1 shared
Most similar at Powderject Vaccines, Inc.
Same institution · by research overlap
- Joel R. Haynes$1,239,823
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseDesignVaccinesVirusInfectionLeadAntigensViralAntibodiesImmunogenicityNonhuman PrimatePreventProteinsDoseImmunityIn VivoCellsInfluenzaT Cell ResponseAnimalsDna VaccinesGeneticResponseImmune
Grant awards (42)
WaNPRC Macaca nemestrina SPF Breeding Colony$2,122,974
U42 · FY2025 · OD · contact PI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$977,255
R44 · FY2025 · AI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$671,529
R01 · FY2025 · AI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$438,089
U19 · FY2025 · AI · contact PI
Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals$300,000
R41 · FY2025 · AI · contact PI
Annual Symposium on Nonhuman Primates$74,999
R13 · FY2025 · OD
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$990,275
R44 · FY2024 · AI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$692,102
R01 · FY2024 · AI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$363,131
U19 · FY2024 · AI · contact PI
Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens$300,000
R44 · FY2024 · AI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$996,500
R44 · FY2023 · AI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$703,773
R01 · FY2023 · AI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$384,249
U19 · FY2023 · AI · contact PI
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$713,861
R01 · FY2022 · AI
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis$442,828
U19 · FY2022 · AI · contact PI
Development of Novel CD180-Based Cancer Immunotherapeutics$398,040
R41 · FY2022 · CA
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics$723,634
R01 · FY2021 · AI
An integrated fiber-microneedle device to study and optimize immune responses$745,214
R56 · FY2020 · DE
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients$907,661
R56 · FY2019 · AI · contact PI
Mucosally-delivered HA stem binding antiviral for influenza$485,210
R33 · FY2019 · AI · contact PI
Programming protective immunity by targeting antigens to the CD180 receptor$435,000
R01 · FY2019 · AI · contact PI
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$298,613
R43 · FY2019 · AI
Mucosally-delivered HA stem binding antiviral for influenza$487,360
R33 · FY2018 · AI · contact PI
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines$300,000
R43 · FY2018 · AI
36th Annual Symposium on Nonhuman Primate Models for AIDS$74,999
R13 · FY2018 · OD · contact PI
Mucosally-delivered HA stem binding antiviral for influenza$493,946
R33 · FY2017 · AI · contact PI
AIDS Mucosal Immunology$443,434
P51 · FY2017 · OD · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,076
R01 · FY2016 · AI · contact PI
Mucosally-delivered HA stem binding antiviral for influenza$288,363
R21 · FY2016 · AI · contact PI
Optimization of a computationally designed antiviral for influenza$209,358
R41 · FY2016 · AI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,075
R01 · FY2015 · AI · contact PI
Mucosally-delivered HA stem binding antiviral for influenza$189,124
R21 · FY2015 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$983,076
R01 · FY2014 · AI · contact PI
Conserved Elements Therapeutic DNA Vaccine for HIV$959,000
R01 · FY2013 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$1,369,470
U01 · FY2011 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$774,843
U01 · FY2010 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$250,000
U01 · FY2010 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$1,238,541
U01 · FY2009 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$1,157,024
U01 · FY2008 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$796,340
U01 · FY2007 · AI · contact PI
DNA Vaccine for Seasonal & Pandemic Influenza$185,544
U01 · FY2007 · AI · contact PI
ADJUVANT DNA VACCINES FOR SYSTEMATIC THERAPY OF AIDS$0
P01 · FY2001 · AI